| Protocol | Description | Details |
| RTOG-0517 | Randomized Phase III Trial to Evaluate RadioPharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast, and Prostate Cancer.
Click on protocol number to see eligibility requirements
Protocol Treatment Modalities:
Other
| Randomized: Yes
Principal Investigator(s):
Parvesh Kumar
Staff Members:
Carryl Du Bois
Carryl Du Bois
|
| RTOG-0534 | A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy.
Click on protocol number to see eligibility requirements
Protocol Treatment Modalities:
Hormone
Radiation: External
| Randomized: Yes
Principal Investigator(s):
Parvesh Kumar
Staff Members:
Carryl Du Bois
Carryl Du Bois
|
| RTOG-0614 | A Randomized Phase III Double-Blind Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy.
Click on protocol number to see eligibility requirements
Protocol Treatment Modalities:
Other
Radiation: External
| Randomized: Yes
Principal Investigator(s):
Paul Pagnini
Staff Members:
Carryl Du Bois
Carryl Du Bois
|
